SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010082
Filing Date
2019-11-06
Accepted
2019-11-06 09:01:25
Documents
80
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrsn-20190930x10q.htm 10-Q 1781312
2 EX-10.1 mrsn-20190930ex101faeead.htm EX-10.1 34352
3 EX-31.1 mrsn-20190930ex3114d82a8.htm EX-31.1 11936
4 EX-31.2 mrsn-20190930ex312f20c4a.htm EX-31.2 13649
5 EX-32.1 mrsn-20190930ex3218ebc49.htm EX-32.1 16054
  Complete submission text file 0001558370-19-010082.txt   7462972

Data Files

Seq Description Document Type Size
6 EX-101.INS mrsn-20190930.xml EX-101.INS 1683340
7 EX-101.SCH mrsn-20190930.xsd EX-101.SCH 54669
8 EX-101.CAL mrsn-20190930_cal.xml EX-101.CAL 57554
9 EX-101.DEF mrsn-20190930_def.xml EX-101.DEF 180979
10 EX-101.LAB mrsn-20190930_lab.xml EX-101.LAB 484814
11 EX-101.PRE mrsn-20190930_pre.xml EX-101.PRE 371536
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 191195238
SIC: 2834 Pharmaceutical Preparations